Turning biotech breakthroughs into viable products is both an art and a science. In this illuminating workshop on commercializing biotech research, you’ll learn how to bridge the gap between the lab and the market. We’ll cover strategies for evaluating the commercial potential of research, protecting intellectual property, assessing regulatory hurdles, and bringing a biotech product to market. You’ll hear real-world stories and gain insights into biotech business models, funding sources, and pitching to investors.
Whether you want to start your own biotech venture or join an existing one, this workshop will equip you with the skills to transform promising research into commercial biotech success. Discover what it takes to monetize innovation in the dynamic world of biotechnology.
ABOUT THE PRESENTER
Michael Fenn is currently head of external innovation at Dewpoint Therapeutics, and is also a venture partner at Iaso Ventures. Previously, Michael was director of healthcare and life sciences at the Harvard Innovation Labs, where he oversaw startup incubation programs and advised Harvard-affiliated founders. Michael also co-led initial planning of Life Lab Longwood, a new translational biotech incubator at Harvard Medical School. Michael was formerly an assistant professor of biomedical engineering at Florida Institute of Technology where his lab focused on the bio-nano interface with applications in drug delivery, biosensing, and regenerative medicine. He successfully oversaw the spinout of two companies from his lab, including a YC-backed, ML-driven diagnostic startup that was later acquired. Michael received his PhD in biomedical engineering, MS in materials science and engineering, and BS in chemistry/biochemistry from the University of Florida.
The Harvard Innovation Labs welcomes attendees of all abilities to our events, both in person and online. If you would like to request accommodations or have questions about physical access, please contact email@example.com in advance of the event.
Please note: By registering, you agree to receive emails about this event and future communications from the Harvard Innovation Labs.